聚合酵素链锁反应市场规模、份额、成长分析，按类型、产品、应用、指示 - 产业预测，2024-2031

2022年全球聚合酵素链锁反应（PCR）市场规模为241.7亿美元，在预测期（2024-2031年）复合年增长率为2.4%，较2023年的247.5亿美元成长。 299.2 亿。

近年来，全球聚合酵素链锁反应（PCR）市场经历了显着成长，并且仍然是分子生物学和诊断领域的重要技术。 PCR 是一种用于扩增和分析 DNA 和 RNA 样本的通用方法，在研究、临床诊断、法医学分析和生物技术等多个领域中发挥基础作用。这种增长是由感染疾病发病率上升、对个性化药物的需求、基因组研究的进步以及对快速、准确的诊断工具（尤其是针对 COVID-19 大流行）的迫切需求等因素推动的。该市场的特点是有许多主要企业提供广泛的 PCR 设备、耗材和服务。传统的 PCR 技术正在发展为更有效率和自动化的系统，例如即时PCR和数位 PCR，提供更快的结果和更高的灵敏度。此外，可携式PCR 设备的开拓正在将市场扩展到现场护理环境。

目录

介绍

• 这项研究的目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场危机与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价值链分析
• 价格分析
• Start-Ups分析
• 监管环境
• 专利分析
• 管道分析
• 成功的关键因素
• 市场吸引力指数
• 竞争程度
• 主要投资机会
• 生态系绘图

按类型：聚合酵素链锁反应(PCR) 市场

• 市场概况
• 标准PCR
• 即时PCR
• 数位PCR
• 其他的

依产品：聚合酵素链锁反应(PCR) 市场

• 市场概况
• 装置
• 试剂/耗材
• 软体和服务

按适应症分類的聚合酵素链锁反应(PCR) 市场

• 市场概况
• 感染疾病
• 肿瘤学
• 遗传疾病
• 其他的

依应用分类：聚合酵素链锁反应(PCR) 市场

• 市场概况
• 医疗保健
  • 临床
  • 病理检查
  • 肿瘤检查
  • 验血
  • 其他的
  • 研究
  • 法医学
  • 其他的
• 非医疗的
  • 食品
  • 其他的

按地区划分：聚合酵素链锁反应(PCR) 市场规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Thermo Fisher Scientific, Inc.（USA）
• Roche Holdings AG（Switzerland）
• Bio-Rad Laboratories, Inc.（USA）
• QIAGEN NV（Netherlands）
• Agilent Technologies, Inc.（USA）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Becton, Dickinson and Company（USA）
• Danaher Corporation（USA）
• Promega Corporation（USA）
• Merck KGaA（Germany）
• Fluidigm Corporation（USA）
• Eppendorf AG（Germany）
• Takara Bio Inc.（Japan）
• Abbott Laboratories（USA）
• BioMerieux SA（France）
• PerkinElmer, Inc.（USA）
• BioFire Diagnostics, LLC（USA）
• Biosearch Technologies, Inc.（USA）
• GenMark Diagnostics, Inc.（USA）
• Enzo Biochem, Inc.（USA）
• Illumina, Inc.（USA）
• New England Biolabs, Inc.（USA）
• Quantabio（USA）
• LGC Limited（UK）
• Bioer Technology Co., Ltd.（China）

Global Polymerase Chain Reaction (PCR) Market size was valued at USD 24.17 billion in 2022 and is poised to grow from USD 24.75 billion in 2023 to USD 29.92 billion by 2031, growing at a CAGR of 2.4% during the forecast period (2024-2031).

In recent years, the global polymerase chain reaction (PCR) market has experienced remarkable growth and remains a crucial technology in molecular biology and diagnostics. PCR, a versatile method for amplifying and analyzing DNA and RNA samples, plays a fundamental role across various fields including research, clinical diagnostics, forensic analysis, and biotechnology. Driving this growth are factors such as the rising incidence of infectious diseases, the demand for personalized medicines, advancements in genomics research, and the urgent need for rapid and accurate diagnostic tools, especially in response to the COVID-19 pandemic. The market is characterized by numerous prominent players offering a wide array of PCR instruments, consumables, and services. Traditional PCR techniques are evolving towards more efficient and automated systems like real-time PCR and digital PCR, offering quicker results and enhanced sensitivity. Furthermore, the development of portable PCR devices has expanded the market's reach into point-of-care settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Polymerase Chain Reaction (PCR) Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Polymerase Chain Reaction (PCR) Market Segmental Analysis

The polymerase chain reaction (PCR) market is segmented based on type, product, indication, end user, and region. By type, the market is segmented into standard PCR, real-time PCR, digital PCR, and others. By product, the market is segmented into instruments, reagents & consumables, and software & services. By indication, the market is segmented into infectious diseases, oncology, genetic disorders, and others. By application, the market is segmented into medical and non-medical. Medical applications are further sub-segmented into clinical (pathology testing, oncology testing, blood screening, and others), research, forensics, and others. Non-medical applications are further sub-segmented into food, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Polymerase Chain Reaction (PCR) Market

PCR is widely employed in molecular diagnostics to detect and monitor various diseases, including infectious diseases, cancer, and genetic disorders. The increasing demand for accurate and swift diagnostic tools, especially amidst the COVID-19 pandemic, has bolstered the need for PCR-based comprehensive tests and diagnostics, a trend expected to continue propelling the PCR market forward.

Restraints in the Global Polymerase Chain Reaction (PCR) Market

The high expenses associated with PCR units and consumables pose a significant obstacle for smaller laboratories, clinics, and research facilities. This financial barrier hampers accessibility to PCR technology in resource-limited settings, potentially impeding market expansion, especially in developing areas.

Market Trends of the Global Polymerase Chain Reaction (PCR) Market

A remarkable trend within the PCR marketplace was the increasing popularity of point-of-care (POC) PCR testing solutions, fueled by the necessity for swift and on-site diagnostic testing, notably amid the COVID-19 pandemic. POC PCR testing presents the advantage of rapid results, proving crucial in scenarios where timely diagnosis is imperative, such as infectious disease outbreaks. As healthcare providers and clinics pursued quicker and more convenient testing options, POC PCR devices and kits gained momentum in the market.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Polymerase Chain Reaction (PCR) Market by Type

• Market Overview
• Standard PCR
• Real-time PCR
• Digital PCR
• Others

Polymerase Chain Reaction (PCR) Market by Product

• Market Overview
• Instruments
• Reagents & Consumables
• Software & Services

Polymerase Chain Reaction (PCR) Market by Indication

• Market Overview
• Infectious Diseases
• Oncology
• Genetic Disorders
• Others

Polymerase Chain Reaction (PCR) Market by Application

• Market Overview
• Medical
  • Clinical
  • Pathology Testing
  • Oncology Testing
  • Blood Screening
  • Others
  • Research
  • Forensics
  • Others
• Non-Medical
  • Food
  • Others

Polymerase Chain Reaction (PCR) Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holdings AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioFire Diagnostics, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosearch Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enzo Biochem, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quantabio (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioer Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments